AGP Executive Report
Last update: 11 hours agoPharma Push: Kazakhstan has approved a KZT 42.5bn private investment for a new pharmaceutical plant in the Karaganda region, aiming to produce 74 drug types and expand high-tech manufacturing (including cancer, autoimmune and rare-disease medicines), with about 70 new jobs. Rare Disease Care: Kazakhstan is also set to open a specialized center for rare genetic skin disorders at the Kazakh Scientific Center of Dermatology and Infectious Diseases, including dedicated treatment and rehab rooms for children with conditions like epidermolysis bullosa. Digital Health Safety: A new QR-code system for blood components is being rolled out to improve patient safety and speed up identification from collection to transfusion. Regional Cooperation: Kazakhstan delivered humanitarian aid to Iran via the Iranian Red Crescent, including medical supplies and medicines. Policy Watch: Kazakhstan’s government has signed a decree to integrate AI across secondary schools between 2026 and 2029, with pilot proposals due June 1.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
